Article Versions Notes

Neogi U, Hill KJ, Ambikan AT, Heng X, Quinn TP, Byrareddy SN, Sönnerborg A, Sarafianos SG, Singh K. Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens. 2020; 9(5):320. https://doi.org/10.3390/pathogens9050320

Neogi, Ujjwal, Kyle J. Hill, Anoop T Ambikan, Xiao Heng, Thomas P. Quinn, Siddappa N. Byrareddy, Anders Sönnerborg, Stefan G. Sarafianos, and Kamal Singh. 2020. "Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs" Pathogens 9, no. 5: 320. https://doi.org/10.3390/pathogens9050320

Neogi, U., Hill, K. J., Ambikan, A. T., Heng, X., Quinn, T. P., Byrareddy, S. N., Sönnerborg, A., Sarafianos, S. G., & Singh, K. (2020). Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs. Pathogens, 9(5), 320. https://doi.org/10.3390/pathogens9050320